Changes impacting the treatment landscape in many blood cancers were discussed this year at the 55th annual meeting of the American Society of Hematology (ASH). Patient Power founder Andrew Schorr shares why physicians, and patients, have reason to be optimistic in his video blog from the conference in New Orleans.
Changes impacting the treatment landscape in many blood cancers were discussed this year at the 55th annual meeting of the American Society of Hematology (ASH). Patient Power founder Andrew Schorr shares why physicians, and patients, have reason to be optimistic in his video blog from the conference in New Orleans.
